These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26444110)

  • 61. Provider and Health System Factors Associated with Usage of Long-Acting Reversible Contraception in Adolescents.
    Smith AJB; Harney KF; Singh T; Hurwitz AG
    J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):609-614. PubMed ID: 28502827
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
    Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
    Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fertility goal-based counseling increases contraceptive implant and IUD use in HIV-discordant couples in Rwanda and Zambia.
    Khu NH; Vwalika B; Karita E; Kilembe W; Bayingana RA; Sitrin D; Roeber-Rice H; Learner E; Tichacek AC; Haddad LB; Wall KM; Chomba EN; Allen SA
    Contraception; 2013 Jul; 88(1):74-82. PubMed ID: 23153896
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
    Broecker J; Jurich J; Fuchs R
    Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices.
    Lam VC; Hadley EE; Berenson AB; Hirth JM; Jennings K; Patel PR
    J Reprod Med; 2016; 61(11-12):529-33. PubMed ID: 30226692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices.
    Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group
    Obstet Gynecol; 2017 Nov; 130(5):e251-e269. PubMed ID: 29064972
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries.
    Ponce de Leon RG; Ewerling F; Serruya SJ; Silveira MF; Sanhueza A; Moazzam A; Becerra-Posada F; Coll CVN; Hellwig F; Victora CG; Barros AJD
    Lancet Glob Health; 2019 Feb; 7(2):e227-e235. PubMed ID: 30683240
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Examining long-acting reversible contraception non-use among Australian women in their 20s: findings from a qualitative study.
    Coombe J; Harris ML; Loxton D
    Cult Health Sex; 2019 Jul; 21(7):822-836. PubMed ID: 30612512
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Did increasing use of highly effective contraception contribute to declining abortions in Iowa?
    Biggs MA; Rocca CH; Brindis CD; Hirsch H; Grossman D
    Contraception; 2015 Feb; 91(2):167-73. PubMed ID: 25465890
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-acting reversible contraception for adolescents.
    McNicholas C; Peipert JF
    Curr Opin Obstet Gynecol; 2012 Oct; 24(5):293-8. PubMed ID: 22781078
    [TBL] [Abstract][Full Text] [Related]  

  • 71. "It's Pretty Hard to Tell Your Mom and Dad That You're on a Method": Exploring How an App Could Promote Adolescents' Communication with Partners and Parent(s) to Increase Self-Efficacy in Long-Acting Reversible Contraception Use.
    Shakibnia EB; Timmons SE; Gold MA; Garbers S
    J Pediatr Adolesc Gynecol; 2018 Apr; 31(2):116-121. PubMed ID: 29024764
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: a randomized, controlled trial.
    Simmons KB; Edelman AB; Li H; Yanit KE; Jensen JT
    Contraception; 2013 Jul; 88(1):45-51. PubMed ID: 23218851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
    Brant AR; Kollikonda S; Yao M; Mei L; Emery J
    Obstet Gynecol; 2021 Nov; 138(5):732-737. PubMed ID: 34619694
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of out-of-pocket costs on the use of intrauterine contraception among women with employer-sponsored insurance.
    Pace LE; Dusetzina SB; Fendrick AM; Keating NL; Dalton VK
    Med Care; 2013 Nov; 51(11):959-63. PubMed ID: 24036995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Achieving cost-neutrality with long-acting reversible contraceptive methods.
    Trussell J; Hassan F; Lowin J; Law A; Filonenko A
    Contraception; 2015 Jan; 91(1):49-56. PubMed ID: 25282161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
    Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
    BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Trends in contraceptive use according to HIV status among privately insured women in the United States.
    Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
    Luo Z; Gao L; Anguzu R; Zhao J
    Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and testing of an iOS waiting room "app" for contraceptive counseling in a Title X family planning clinic.
    Gilliam ML; Martins SL; Bartlett E; Mistretta SQ; Holl JL
    Am J Obstet Gynecol; 2014 Nov; 211(5):481.e1-8. PubMed ID: 24881829
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mental health diagnoses and early removal of long-acting reversible contraception.
    Bello JK; Salas J; Meyer D; Heiden-Rootes K; Davis DM; Keegan Garrett E; White MM; Schmeidler P
    J Affect Disord; 2020 Feb; 262():333-336. PubMed ID: 31740110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.